Patient Access
Researchers found a 43.4% mean reduction in patient-rated obsessive-compulsive symptoms.
The app has been recommended as an effective alternative to sleeping pills in the UK.
Also: Pear Therapeutics reported $2.7 million in revenue for its first quarter compared with $1.3 million in Q4 2021.
On the heels of a $9.2 million Series A, Mahmee CEO and cofounder Melissa Hanna discusses the fragmented maternal healthcare experience in the U.S.
The solution uses gamification to increase patient adherence.
Also: Women's healthcare provider Tia expands into fertility care.
The startup launched in August last year with a $3.2 million seed.
Cerebral is halting prescriptions such as Adderall and Xanax for current and new patients.
Authors of the study said the results raise concerns about worsening health disparities, especially when models can detect self-reported race information where human radiologists can't.
With the need for mental health support growing, could DTx be the key to making treatment more accessible?